Patents by Inventor Bruno Gielthen

Bruno Gielthen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-(3-AMINOARYL) AMINO-4-ARYL-THIAZOLES AND THEIR USE AS C-KIT INHIBITORS
    Publication number: 20080255141
    Abstract: Novel compounds selected from 2-(3-aminoaryl)amino-4-aryl-thiazoles of formula (I) that selectively modulate, regulate, and/or inhibit signal transductions mediated by certain native and/or mutant tyrosine kinases implicated in a variety of human and animal diseases such as cell proliferation metabolic, allergic and degenerative disorders. More particularly, these compounds are potent and selective c-kit inhibitors.
    Type: Application
    Filed: July 18, 2007
    Publication date: October 16, 2008
    Inventors: Marco Ciufolini, Camille Wermuth, Bruno Gielthen, Alain Moussy
  • 2-(3-Aminoaryl)amino-4-aryl-thiazoles for the treatment of diseases
    Patent number: 7423055
    Abstract: The present invention relates to novel compounds selected from 2-(3-aminoaryl)amino-4-aryl-thiazoles that selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant tyrosine kinases implicated in a variety of human and animal diseases such as cell proliferative, metabolic, allergic, and degenerative disorders. More particularly, these compounds are potent and selective c-kit inhibitors.
    Type: Grant
    Filed: August 1, 2003
    Date of Patent: September 9, 2008
    Assignee: AB Science
    Inventors: Marco Ciufolini, Camille Wermuth, Bruno Gielthen, Alain Moussy
  • 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
    Publication number: 20050239852
    Abstract: Novel compounds selected from 2-(3-aminoaryl) amino-4-aryl-thiazoles of formula (I) that selectively modulate, regulate, and/or inhibit signal transductions mediated by certain native and/or mutant tyrosine kinases implicated in a variety of human and animal diseases such as cell proliferative, metabolic, allergic and degenerative disorders. More particularly, these compounds are potent and selective c-kit inhibitors.
    Type: Application
    Filed: July 31, 2003
    Publication date: October 27, 2005
    Applicant: AB Science
    Inventors: Marco Ciufolini, Camille Wermuth, Bruno Gielthen, Alain Moussy
  • 2-(3-Aminoaryl)amino-4-aryl-thiazoles for the treatment of diseases
    Publication number: 20040110810
    Abstract: The present invention relates to novel compounds selected from 2-(3-aminoaryl)amino-4-aryl-thiazoles that selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant tyrosine kinases implicated in a variety of human and animal diseases such as cell proliferative, metabolic, allergic, and degenerative disorders. More particularly, these compounds are potent and selective c-kit inhibitors.
    Type: Application
    Filed: August 1, 2003
    Publication date: June 10, 2004
    Applicant: AB Science
    Inventors: Marco Ciufolini, Camille Georges Wermuth, Bruno Gielthen, Alain Moussy